Depression and insomnia;Depresja i bezsenność

Wiadomosci Psychiatryczne

Volumn 9, Issue 2, 2006, Pages 99-107

  Krysiak, Katarzyna ^a   Jarema, Marek ^a  

^a Instytut Psychiatrii i Neurologii III Klinika Psychiatryczna Warszawa   (Poland)

Author keywords

Antidepressant agents; Depression; Insomnia

Indexed keywords

EID: 34547783732     PISSN: 15057429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Ruth MB, M. Special considerations in insomnia diagnosis and management: depressed, elderly and chronic pain population. J Clin Psychiatry 2004.
2. Roth T, Roehrs T. Insomnia: epidemiology, characteristics and consequences. Clin Cornestrone 2003; 5 (3): 5-15.
3. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003; 37: 9-15.
4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? Jama 1989; 262: 1749-1484.
5. Shochat T, Umphress J, Israel AG, et al. Insomnia in primary care patients. Sleep 1999; 22 (Suppl. 2): 359-365.
6. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania w ICD-10. Kraków-Warszawa: Uniwersyteckie Wydawnictwo Medyczne Vesalius, Instytut Psychiatrii i Neurologii; 1998.
7. Armitage R. The effects of antidepressants on sleep in patients with depression. Can J Psychiatry 2000; 45: 803-809.
8. Fava M. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry 1994: 65 Suppl. 16: 27-32.
9. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? Jama 1989; 262: 1749-1484.
10. Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146: 105-114.
11. Perlis ML, Giles DE, Bursse DJ, et al. Which depressive symptoms are related to witch sleep electroencephalographic variables? Biol Psychiatry 1997; 42: 904-913.
12. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39: 411-418.
13. Pedis ML, Giles DE, Buysse DJ, et al. Self-reported sleep disturbances as a prodromal symptom in recurrent depression. J Affect Disord: 1997; 42: 209-212.
14. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999; 60 (Suppl. 17): 28-31; discussion 46-48.
15. Boyle A. A novel approach to the psychopharmacologic treatment of insomnia in depression. Med Hypotheses 2004; 63: 26-30.
16. Rechtschaffen A, Kales A. A manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subject 1968.
17. Benca RM, Obermeyer WH, Thisted RA, et al. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 1992; 49: 651-668.
18. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995; 37 (2): 85-98.
19. Thasse ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999; 60 (Suppl. 17): 28-31.
20. Rush AJ, Ermar MK. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psych 1986; 43: 878-884.
21. Shipley JE, Kupfer D, Griffin SJ, Dealy RS, Coble PA, Mc Eachran AB, et al. Comparison of effects of desipramine and amitryptyline on EEG sleep of depressed patients. Psychopharmacology 1985; 85 (1): 14-22.
22. Hartmann E, Cravens J. The effects of long-term administration of psychotropic drugs on human sleep: III. The effect of amitryptyline. Psychofarmacologia 1973; 33: 185-202.
23. Gillin JC, Wyatt RJ, Fram D, Snyder F. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitryptyline. Psychopharmacology 1978; 59: 267-272.
24. Sonntag A, Rothe B, Guldner J, Yassourdidis A, Holsboer F, Steiger A. Trimipramine and imipramine exert different effects on the sleep EEG and an nocturnal hormone secretion during treatment of major depression. Depression 1996; 4 (1): 1-13.
25. Feillade P, Pringuey D, Belugou JL, Robert P, Darcout G. Trimipramine acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 1992; 24: 135-145.
26. Passouant P, Caedhilac J, Billard M. Withdrawal of the paradoxical sleep by the domipramine, electrophysiological, histochemical and biochemical study. Int J Neurol 1975; 10: 186-197.
27. Grimsley S, John M. Paroxetine, sertraline and fluvoxamine. New selective serotonin reuptake inhibitors. Clin Pharmacy 1992; 11: 930-957.
28. Rascati K. Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety sleep medication. Clin Ther 1995; 17: 786-790.
29. Rush AJ, Amitage R, Gillin C, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 1998; 44: 3-13.
30. Jindal RD, Friedman ES, Berman SR, Fasiczka AL, Howland RH, Thase ME. Effects of sertraline on sleep architecture in patients with depression. J Clin Psychopharmacol 2003; 23 (6): 540-548.
31. Gillin JC, Erman MK, Winokur A, Albala BJ. A comparison of nefazodone and floxetine on mood and on objective, subjective, and clinician- rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 1997; 58: 185-192.
32. Dorsey CM, Lukas SE, Cunningham SL. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 1996; 14 (6): 437-442.
33. Oswald J, Adam K. Effects of paroxetine on human sleep. Br J Clin Pharmacology 1986; 22: 97-99.
34. Wilson SJ, Bailey JE, Rich AS, Adrover M, Potokar J, et al. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol 2004; 14 (5): 367-372.
35. Van Bemmel AL, van den Hoofdkker RH, Beersma DG, Bouhuys AL. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology (Berl.) 1993; 113 (2): 225-230.
36. Wilson SJ, Bailey JE, Rich AS, Adrover M, Potokar J, Nutt DJ. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol 2004; 14 (5): 367-372.
37. Sewitch D, Biniaur I, Phillips J. Sleep architecture and mood effects of sertraline in outpatients with major depression: a preliminary report. Sleep Res 1991; 20: 189.
38. Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski VJ, Wilson MI, et al. McEachran AB. Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry 1991; 29 (1): 23-40.
39. Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 1997; 58 (4): 146-152.
40. Oberndorfer S, Saletu-Zyhlarz G, Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychology 2000; 42 (2): 69-81.
41. Luthringer R, Toussaint M, Schaltenbrand N, Bailey P, Danjou PH, Hackkett D, et al. A double-blind, placebo-controlled evaluation of orally administered venlafaxine on sleep in patients with major depression. Psychopharmacol Bull 1996; 32 (4): 637-646.
42. Monti JM. Effect a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry 1989; Suppl. 155: 61-65.
43. Mendlewicz J, Dunbar GC, Hoffman G. Changes in sleep EEG architecture during the treatment of depressed patients with mianserin. Acta Psychiatr Scand 1985; Suppl. 320: 264-29.
44. Winokur A, DeMartinis NA 3rd, McNally DP, Gary EM, Cormier JL, Gary KA. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003; 64: 1224-1229.
45. Winokur A, Sateia MJ, Hayes JB, Baylesi-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000; 48: 75-78.
46. Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology 2003; 48: 194-208.
47. Dubovsky SL, Thomas M. Beyond specificity: effects of serotonin and serotoninergic treatments on psychobiological dysfunction. J Psychosom Res 1995; 39: 429-444.
48. Stahl S M. Essential Psychopharmacology of depression and Bipolar Disorders. Cambridge University Press 2000.
49. Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M. Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology (Berl.) 1988; 95 (Suppl): 37-43.
50. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, Gruber G, Mandl M, Strobl R, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26: 249-260.
51. Blacker R, Shanks NJ, Chapman N, et al. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitryptyline. Psychopharmacology 1958; 95: 18-24.
52. Jones D, et al. Sleep and depression. Psychopathology 1987; 20 (Suppl 1): 20-31.
53. Gerner RH. Geriatric depression and treatment with trazodone. Psychopathology 1987; 20 (Suppl 1): 83-91.
54. Armitage R, Yonkers K, Cole D, Rush AJ. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacology 1997; 17: 161-168.
55. Nierenberg AA, Adler LA, Peselow E, et al. Trazodon for antidepressant-associated insomnia. Am J Psychiatry 1994; 151: 1069-1072.
56. Andrew D, Krystal MD. The changing perspective on chronic insomnia management. J Clin Psychiatry 2004; 65 (Suppl. 8): 20-25.
57. Prusiński A. Bezsenność i jej leczenie. Neurol Neurochir Pol 1999; 32 (Suppl 6): 51-60.
58. Uchimura N, Nakajima T, Hayash K, et al. Effect of Zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam. Prog Neuropsychopharm Biol Psych 2005; 25: 25-35.
59. Morin CM, Mimeault V, Gagne A. Non pharmacological treatment of late-life insomnia. J Psychosom Res 1999; 46 (2): 103-116.